Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Avomeen Analytical Services has hired Khanh Ngo Courtney as its Biological Chemistry Project Director. Through this newly created position, Courtney will help grow Avomeen’s large-molecule and protein therapeutics business segment by partnering with ...
read more
GeneCentric Therapeutics has acquired Select ImmunoGenomics, a Chapel Hill, NC-based provider of advanced immunogenomic, data analysis and biomarker development services to support the development of immuno-oncology drugs. The acquisition provides ...
read more
Marker Therapeutics has announced the appointment of Nadia Agopyan, Ph.D., RAC as Vice President of Regulatory Affairs, effective August 15.
"We are pleased to welcome a professional of Nadia's caliber and senior leadership experience to Marker," ...
read more
Berkshire Sterile Manufacturing (BSM) announces its plan to add a third isolator line to expand capacity for future commercial clients. BSM is a state-of-the-art fill/finish contract manufacturer providing formulation and sterile filling services to ...
read more
AskBio has acquired Synpromics, a provider of gene control synthetic promoter technology, bioinformatics and intelligent data-driven design that enables more precise cell targeting and gene expression.
read more
EAG Laboratories has announced the launch of a new laboratory in China dedicated to improving materials, products and electronics. Built in Shanghai, this facility brings the advanced imaging and surface analysis expertise and technology to China, ...
read more
Wednesday, August 21, 2019
IQVIA™ has announced the launch of the IQVIA Patient Portal, a global web-based solution built on a leading health cloud platform. This innovative tool enables increases in clinical trial patient recruitment, engagement and retention by ensuring ...
read more
Wednesday, August 21, 2019
Marken has announced that its nursing services for home-based clinical trials are now operational in most key markets around the world, which can be integrated into its already well-established logistics network. The home healthcare offering extends ...
read more
Wednesday, August 21, 2019
VirTrial has announced a training and certificate program to help clinical research professionals prepare for hybrid decentralized clinical trials (DCT) which include a combination of virtual and in-person visits. The program is free to all members ...
read more
Wednesday, August 21, 2019
LabConnect, a leading global provider of central laboratory and support services for biopharmaceutical, pharmaceutical, medical device, and contract research organizations, has hired Mr. Tom Sellig to serve as its new Chief Executive Officer as well ...
read more
Wednesday, August 21, 2019
Orexo has entered into an exclusive agreement with GAIA AG for a new digital therapy (DTx) for the treatment of Opioid Use Disorder (OUD). Orexo will have the exclusive global commercial rights to the product and intends to launch it in the US in ...
read more
Wednesday, August 21, 2019
Endo International has applauded the U.S. District Court for the District of Columbia's decision supporting the Food and Drug Administration's (FDA) determination that vasopressin cannot be used for compounding by outsourcing facilities. The Court ...
read more
Phesi, a data-driven provider of premier integrated clinical development analytics products and services, today announced the appointment of Otis Johnson, PhD, MPA, as the company’s chief commercial officer. Dr. Johnson’s primary responsibility will ...
read more
Cantargia AB and BioWa Inc. have signed an extension of the license agreement around the BioWa proprietary POTELLIGENT® Technology for production of Cantargia's antibody drug candidate CAN04, which gives Cantargia broader rights to use the technology...
read more
Evidera, a business unit of Pharmaceutical Product Development, LLC (PPD), has entered into an exclusive collaboration agreement with Clinical Study Support, Inc. (CSS), a subsidiary of Shin Nippon Biomedical Laboratories Ltd. (SNBL), extending both ...
read more